Holen Sie sich die Stockscreener-App
3.2699
0.20%
-0.0064
Handel nachbörslich:
3.27
0.0001
+0.00%
Schlusskurs vom Vortag:
$3.2763
Offen:
$3.26
24-Stunden-Volumen:
35,685
Relative Volume:
1.12
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.68%
1M Leistung:
-31.39%
6M Leistung:
-37.72%
1J Leistung:
-20.83%
1-Tages-Spanne:
$3.23
$3.3092
1-Wochen-Bereich:
$3.20
$3.47
52-Wochen-Spanne:
$3.01
$6.48
Amplify Seymour Cannabis Etf Stock (CNBS) Company Profile
Firmenname
Amplify Seymour Cannabis Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CNBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CNBS | 3.2699 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Amplify Seymour Cannabis Etf Aktie (CNBS) Neueste Nachrichten
Marijuana rescheduling unlikely to lead to cannabis banking reform - MSN
Weed stocks spike after report on Trump support for marijuana reforms - MSN
6 Best-Performing Marijuana ETFs for November 2024 - NerdWallet
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - MSN
Cannabis stocks rebound amid DEA rescheduling review - MSN
EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts Say - Benzinga
Victory In Commerce Clause Case Could Be The Silver Bullet For Cannabis Industry, Experts Say - Benzinga
7 Best Marijuana ETFs to Consider in 2024 - The Motley Fool
122,438 Shares in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) Bought by Gateway Wealth Partners LLC - Defense World
Wealth Alliance Makes New Investment in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) - Defense World
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed By Invezz - Investing.com Canada
Marijuana ETFs: The Pros and Cons - Investopedia
Here's Why Tilray Brands Has Become a Much Better Buy Than Canopy Growth - The Motley Fool
CNBC’s Tim Seymour takes ‘glass half full’ view of second quarter cannabis earnings - Green Market Report
Cannabis Investing In The Age Of Legalization With Julian Lin, Tim Seymour And Pablo Zuanic - Seeking Alpha
5 Best Cannabis ETFs to Invest In - Securities.io
Amplify Seymour Cannabis ETF (CNBS-A) QuotePress Release - The Globe and Mail
How to invest in cannabis stocks - CNN Underscored
Cannabis Investing In The Age Of Legalization - Seeking Alpha
Cannabis ETFs are off to a strong September. Will the buzz last? - MSN
Cannabis is a $200B market cap industry, analyst says at SA Investing Summit - MSN
Cannabis is a $200B market cap: Pablo Zuanic (NYSEARCA:MSOS) - Seeking Alpha
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth - Markets Insider
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth' - Markets Insider
6 Best-Performing Marijuana ETFs for June 2024 - NerdWallet
Could Rescheduling Finally Bring Institutional Investment in to Cannabis? - Business of Cannabis -
Cannabis rally sparks concerns amid moves to mainstream - MSN
How the (CNBS) price action is used to our Advantage - Stock Traders Daily
7 Best Marijuana ETFs to Buy in 2024 - U.S News & World Report Money
Best ETF Areas of Last Week - Yahoo Finance
Marijuana ETF Space Gets Packed - Yahoo Movies Canada
Cannabis ETFs Soar On Reports DEA Plans To Reclassify Marijuana - Forbes
Marijuana stocks rise on cannabis rescheduling (NYSEARCA:MSOS) - Seeking Alpha
Cannabis stocks gain as DEA pressed for marijuana rescheduling - Seeking Alpha
The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail
Cannabis Stocks Shine As Benzinga's Cannabis Capital Conference Unfolds - Benzinga
Is Rescheduling a Certainty for Cannabis? ETFs That Surge - Yahoo Finance
Cannabis ETFs Jump on Imminent Rescheduling News - Yahoo Finance
Understanding Cannabis ETFs’ Wacky Divergence - ETF Trends
Cannabis stocks rebound amid DEA's rescheduling review - Seeking Alpha
Cannabis Stocks: Why Tomorrow Might Be Too Late To Invest And How To Pick The Right Stocks - Benzinga
Marijuana ETFs Rise – and Fall – on Regulatory Hopes - ETF Trends
Cannabis Stocks & ETFs: Can the Recent Surge Continue? - Yahoo Lifestyle Australia
Top Performing ETFs: Cannabis ETFs Lead - Nasdaq
MJ: The Long Awaited Breakout For Marijuana Stocks Is Here! - TheStreet
Amplify's Christian Magoon on Purchase of ETFMG's ETFs - ETF Trends
Here’s Why These Cannabis ETFs Aren’t Very Good - New Cannabis Ventures
'The Only Thing We Can Do As An Industry Is Learn,' Says Emily Paxhia On Navigating The Cannabis Investment Landscape - Benzinga
VA And DoD Face Criticism From Rep. Blumenauer Over 'Misguided' Denial Of PTSD Treatment With Medical Can - Benzinga
Worst Performing ETFs of the Year - etf.com
How to Buy Marijuana Stocks: A Beginner's Guide - Money
Finanzdaten der Amplify Seymour Cannabis Etf-Aktie (CNBS)
Es liegen keine Finanzdaten für Amplify Seymour Cannabis Etf (CNBS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):